This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Biotech

Amgen Indulges in Another Rheumatoid Arthritis Drug Price Increase

Amgen Indulges in Another Rheumatoid Arthritis Drug Price Increase

The hike in Enbrel's list price pushed through by Amgen illustrates again how drug companies profit by raising the cost of their older medicines to offset falling prescription volume.

05/05/15 - 02:43 PM EDT

Netflix Spikes on Upgrade; Bloomin' Brands Revises Forecast

The Nasdaq tumbled below 5,000 in midday trading Tuesday. Netflix (NFLX) gained after Bank of America upgraded shares to BUY from UNDERPERFORM.

05/05/15 - 12:04 PM EDT

NewLink Insiders Sell Stock While Moss Grows on Pancreatic Cancer Vaccine Analysis

NewLink Insiders Sell Stock While Moss Grows on Pancreatic Cancer Vaccine Analysis

  • Tickers in this article:
  • NLNK

The wait goes on for NewLink Genetics to disclose the second interim analysis from the ongoing phase III study of its pancreatic cancer vaccine.

05/05/15 - 10:40 AM EDT

Netflix Spikes on Upgrade; Bloomin' Brands Revises Forecast

Netflix Spikes on Upgrade; Bloomin' Brands Revises Forecast

The Nasdaq tumbled below 5,000 in midday trading Tuesday. Netflix (NFLX) gained after Bank of America upgraded shares to BUY from UNDERPERFORM.

05/05/15 - 12:04 PM EDT

Shades of 1990s in Social Media Earnings Misses: Best of Kass

Shades of 1990s in Social Media Earnings Misses: Best of Kass

In highlights from his trading diary of the past week, Kass pointed to similarities between high-profile social media and biotech earnings misses and certain Internet stocks in the late 1990s.

05/03/15 - 04:53 PM EDT

Altera Leads S&P 500 on Deal Talk; Stocks Kick Off May With Rally

Altera Leads S&P 500 on Deal Talk; Stocks Kick Off May With Rally

Altera (ALTR) was the best performer on the S&P 500 on reports Intel (INTC) could launch a hostile bid once a standstill agreement expires on June 1st.

05/01/15 - 04:38 PM EDT

As Stocks Flirt With All-Time Highs, Investors Should Be 'On Edge' About a Correction

As Stocks Flirt With All-Time Highs, Investors Should Be 'On Edge' About a Correction

Stocks may be flirting with record highs, but don't get too comfortable, one strategist warns.

05/01/15 - 03:08 PM EDT

Despite April's Rocky Finish, Don't Sell in May and Go Away

Despite April's Rocky Finish, Don't Sell in May and Go Away

This year, the CNBC 'Fast Money Halftime' traders aren't following the classic strategy of getting out of the market during the summer doldrums, because now, they see a buying opportunity.

05/01/15 - 02:52 PM EDT

Jim Cramer -- BioMarin, Receptos Will Re-Test Highs, Biotech Will Recover

Jim Cramer -- BioMarin, Receptos Will Re-Test Highs, Biotech Will Recover

TheStreet's Jim Cramer says the rally in biotech stocks is far from over.

05/01/15 - 11:40 AM EDT

Biotech Stock Mailbag: Biotech Bull So Insanely Good It Will Make You Forget Week's Pain

Biotech Stock Mailbag: Biotech Bull So Insanely Good It Will Make You Forget Week's Pain

Biotech columnist Adam Feuerstein answers readers' questions about health care.

05/01/15 - 08:31 AM EDT

Apple Leads Dow Lower; Wall Street Slumps on Biotech Selloff

Apple Leads Dow Lower; Wall Street Slumps on Biotech Selloff

Stocks slumped on Thursday, leaving the Dow with only small gains for the month.

04/30/15 - 04:35 PM EDT

MannKind Afrezza Contributes to Sanofi's Subpar Diabetes Unit Sales

MannKind Afrezza Contributes to Sanofi's Subpar Diabetes Unit Sales

  • Tickers in this article:
  • MNKD
  • SNY

Sales of MannKind's inhaled insulin Afrezza totaled €1 million in the first quarter of its commercial launch.

04/30/15 - 06:51 AM EDT

Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings

Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings

  • Tickers in this article:
  • MNKD
  • SNY

Sanofi reports first-quarter earnings on Thursday morning, but it's unclear if sales of the recently launched inhaled insulin medication Afrezza will be disclosed.

04/29/15 - 01:18 PM EDT

Mylan, Perrigo Active on Boosted Bid; Starwood Explores Options

Mylan, Perrigo Active on Boosted Bid; Starwood Explores Options

Stocks were lower in midday trading Wednesday after U.S. economic growth turned anemic in the first quarter.

04/29/15 - 12:00 PM EDT

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

DOW 17,928.20 -142.20 -0.79%
S&P 500 2,089.46 -25.03 -1.18%
NASDAQ 4,939.3270 -77.6020 -1.55%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs